Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I suspect the shareholder list would contain a fair number of nominees.
How does an oil index like XOI correlate to theprice of oil?
I've got to start liquidating a few stocks to make a cash offer on a house down here, and a few oilies are on my hit list, though not yet confirmed kills.
It will be sad to see some of them (e.g. HK)go.
Who are most?
According to Fidelity (usually accurate in such things) ex was 2/24, pay 4/8. Should have no current effect on share movement given that the ex was a month ago.
The Japanese demonstrated at the battle of Midway that crisis response is not their strong suit, and they seem to remain true to form<G>
Do they have much choice, plus the Fukushima contretemps can be ascribed to antiquated BW design.
If you believe Ann Coulter, the right amount of radiation exposure actually confers longevity benefits.
The right amount, of course.
With bid/ask spreads that are usually pretty wide (a nickel or more) TRGT is tough to scalp or day trade. Has the spread tightened recently?
They procrastinated for over a decade hoping to avoid the day of reckoning on the large banks' bad loan portfolios.
It's a pathetic disgrace.
Similarly, it would be helpful if QE2 were directed towards infrastructure rather than the purchase of financial instruments.
Not directly infrastructure, but like Brazil burned the coffee crop in the 30's.
Not only approved, but expensive yet.
the skepticism seems to be deeper among posters on internet chat boards than among people who work in the oil industry.
A wrinkle in Canadian corporate law?
And there are some who are skeptical that the Saudi excess capacity actually exists.
Sun Feb 20, 3:05 pm ET
WASHINGTON (AFP) – A growing, more affluent population competing for ever scarcer resources could make for an "unrecognizable" world by 2050, researchers warned at a major US science conference Sunday.
The United Nations has predicted the global population will reach seven billion this year, and climb to nine billion by 2050, "with almost all of the growth occurring in poor countries, particularly Africa and South Asia," said John Bongaarts of the non-profit Population Council.
To feed all those mouths, "we will need to produce as much food in the next 40 years as we have in the last 8,000," said Jason Clay of the World Wildlife Fund at the annual meeting of the American Association for the Advancement of Science (AAAS).
"By 2050 we will not have a planet left that is recognizable" if current trends continue, Clay said.<SNIP>
When I was looking at my options and researching Davinci, I was told 400 procedures was the magic number.
Sobering.
Simply needed to free up funds to put elsewhere and the bored response to the earnings deceived me into thinking it would stay boring.
One reason might be that I sold my LGND yesterday because the earnings were a yawner.
This article is from Dec 2010, but the premise has not changed since then, as far as I know.]
Right - please ascribe it weekend non compos mentis and forgive me.
What did genisi mean by Lupin's? ? The drug or Italpharma?
In Jan US added 36,000 jobs but the rate declined to 9%. Gimme a break
Look at the bright side. As someone pointed out on SI, just add a few hundred thousand more jobs on that basis and the rate will be zero.
Merchant of Venice, Act IV, Scene I.
Back on the main point, I fail to understand why people ignore the possibility that Teva resubmitted with an improved product in face of either a rejection or other bad feedback.
Spooky.
They had me twice, but with an out of date address and phone #. They had the right estimate for our house though - several hundred k less than we paid for it.
Then we're back to RR's point - if that's what they've got in front of the FDA it would have been thrown out long ago, or at the very least would not be approved as a substitutable product.
Both VHC and CCME are normal margin stocks at Fido.
I own some, but I would say it's a volatility capture play - 20% swings in two trading days is more than I want in an IRA. So it (the stock) will have to start behaving more normally or it's gone.
Some of the spreads in the options are pretty wide tho, in spite of the relatively high volume. Incredible IV's, high volume today. Tempting indeed.
Thanks for raising the options possibility.
Since I bought at 3.20
despite a much stronger BS.
It was meant to be congratulatory, not sarcastic!
Should have resisted the urge to get up and pee. I have a small number of NVS shares which I was debating selling yesterday. Won't help MNTA.
LONDON/ZURICH, Jan 27 (Reuters) - Drugmakers AstraZeneca (AZN.L) and Novartis (NOVN.VX) set a cautious tone for the year ahead on Thursday, bracing the sector for challenging patent expiries and price pressures from U.S. health reforms.
While AstraZeneca delivered above-forecast fourth quarter earnings and a promise to buy back $4 billion of shares, it joined its Swiss rival in warning that pressure from generics, U.S. healthcare reform and price cuts would take their toll.
Novartis, the first European drugmaker to report in this earnings season, missed analysts' expectations with fourth quarter core earnings per share of $1.14 and said it expected its sales for 2011 to be lower.
Astra is facing pricing pressure from key competitor brands losing exclusivity, such as Pfizer's (PFE.N) Lipitor, which competes in the statin market with its blockbuster Crestor.
"The coming years will be challenging for the industry and for the company as its revenue base transitions through a period of exclusivity losses and new product launches," Astra said in a statement<snip>
12.50? that was one hell of a trade.
So did I, at 13.20, though I usually avoid buying opportunities like the plague.
The FT does have such a disclaimer.
Copyright The Financial Times Limited 2011. You may share using our article tools. Please don't cut articles from FT.com and redistribute by email or post to the web.
I thought the presence of the TEVA GC was significant. A possible scenario is that Marth was riding unfettered until the MNTA suit forced the GC to focus on the implications of Marth making unsubstantiatable promises to the market re tEnox approvability. At that point the lawyers may have had a "Houston, we have a problem" moment. And Marth was muzzled.
Herd mentality is a stupid word for this board, as most posters here can and do think for themselves - many people with deep knowledge of the topic they're opining on - but it would be equally absurd to think that a position shift by Dew re MNTA would not have a tectonic shift effect. I think that's all DFRAI was trying to say, albeit awkwardly.
I have a very small position in MNTA, which is why this board is one of the first places I go to in the morning. Don't want to get left behind.
The market makers in the options market are analogous to the house in poker
That depends completely on the stock in question. Many liquid options have 1 or 2 cent spreads. After that it's a question of my volatility assumptions vs the market maker's. He may be right, he may be wrong.
Agree however that the wide spreads and illiquid option series are guaranteed destruction. Granted you can usually trade between the posted spread, but it's hard to make any money in some of the 66% spreads I see. Plus the lack of liquidity make some of them a roach motel where one has to accept whatever the market maker deigns to give you.